Gaetano Morelli, Chief Medical Officer at Altasciences, noted: "As we learn more about GLP-1 RAs, we realize that they target many organ systems, including the pancreas, stomach, brain, heart, kidneys, immune system (due to reduced inflammation), skeletal muscle, and control of white and brown adipose tissue metabolism, with positive effects in fatty liver disease." Because these drugs address multiple chronic conditions simultaneously, they warrant broader clinical use
This in turn may enhance Lcarnitines benefits
For example: Acupuncture has been shown in controlled studies to reduce chemotherapyinduced nausea, pain, anxiety, and hot flashes
The medication carries a boxed warning regarding this risk